LGALS1 and cancer: The present results demonstrate that a significant fraction of human serum α-2-macroglobulin, IgM and haptoglobin, bind to galectin-1 and that the total amount of galectin-1-binding glycoproteins can be 2–3 times larger in sera of some cancer patients.